Journal
MARINE DRUGS
Volume 18, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/md18060327
Keywords
diterpenoids; dendrillins; malaria; leishmaniasis; MRSA biofilm
Categories
Funding
- Nation Science Foundation from the Antarctic Organisms and Ecosystems Program [PLR-1341333, PLR-1341339]
- NIH [AI103673, AI103715, AI124458]
- State of Florida for Center of Excellence funding of the Center for Drug Discovery and Innovation
Ask authors/readers for more resources
The Antarctic spongeDendrilla antarcticais rich in defensive terpenoids with promising antimicrobial potential. Investigation of this demosponge has resulted in the generation of a small chemical library containing diterpenoid secondary metabolites with bioactivity in an infectious disease screening campaign focused onLeishmania donovani,Plasmodium falciparum, and methicillin-resistantStaphylococcus aureus(MRSA) biofilm. In total, eleven natural products were isolated, including three new compounds designated dendrillins B-D (10-12). Chemical modification of abundant natural products led to three semisynthetic derivatives (13-15), which were also screened. Several compounds showed potency against the leishmaniasis parasite, with the natural products tetrahydroaplysulphurin-1 (4) and dendrillin B (10), as well as the semisynthetic triol15, displaying single-digit micromolar activity and low mammalian cytotoxicity. Triol15displayed the best profile against the liver-stage malaria parasites, while membranolide (5) and dendrillin C (11) were strong hits against MRSA biofilm cultures.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available